Nasdaq and S&P 500 headed for best three months since the pandemic recovery. Here's why most investors won't see the same ...

Unicyive Therapeutics is awaiting word on whether its main drug, oxylanthanum carbonate, will be approved to treat ...

Citizens has raised its price target on Backblaze to $14 from $8 and kept an ‘Outperform’ rating on the stock, according to ...

The "Magnificent Seven" stocks — which include Alphabet, Amazon, Apple, Microsoft, Meta Platforms, Nvidia and Tesla — have ...

Morgan Stanley thinks Apple’s big price hike is seen as "an unprecedented push to protect margins." ...

SpaceX lived up to the hype over its first three trading days, peaking at about $226 on June 16, a 50% increase from its first-day open. It was even the world's fourth-largest company at one point, ...

After three straight years of 10% or greater returns for the S&P 500, gains in year four are typically more subdued. But that doesn't mean 2026 won't be another great year for stocks. A fourth ...

Semiconductor stocks were on track to be the top-performing S&P 500 industry group on Monday, even as the rally continued to broaden out into more cyclically sensitive corners of the market following ...

Information overload is now a thing of the past with the Stocks.News app - available for no cost download for iOS and Android. Even with the financial landscape embracing new levels of digitization, ...